An Open-label, Multiple-dose Study of Acalabrutinib, Co Administered With a Proton-pump Inhibitor, in Participants Hospitalized With COVID-19
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008227/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Study D822FC00005 will investigate the Phamacokinetics, Safety and tolerability of
Acalabrutinib suspension when delivered via a nasogastric tube and co-administered with a
Proton Pump Inhibitor, in the treatment of COVID-19.
提供机构：
Vivli
创建时间：
2022-07-06
